The Journal of Nutrition Health and Aging

, Volume 12, Issue 3, pp 202–206 | Cite as

Prevalence of sarcopenia in the French senior population

  • J. Tichet
  • S. Vol
  • D. Goxe
  • A. Salle
  • G. Berrut
  • P. Ritz
Geriatric Science

Abstract

Introduction A muscle mass normalized for height2 (MMI) or for body weight (SMI) below 2SD under the mean for a young population defines sarcopenia. This study aimed at setting the cutoffs and the prevalence of sarcopenia in the French elderly population. Another objective was to compare the results obtained with SMI and MMI.Methods: Muscle mass was assessed by bioelectrical impedance analysis in 782 healthy adults (<40 years) to determine skeletal mass index (SMI, muscle mass*100/weight) and muscle mass index (MMI, muscle mass/height2). Prevalence was estimated in 888 middle aged (40–59 years) and 218 seniors (60–78 years). All were healthy people.Results: For women mean-2SD were 6.2 kg/m2 (MMI) and 26.6% (SMI); for men limits were 8.6 kg/m2 (MMI) and 34.4% (SMI). In middle aged persons a small number of them were identified as sarcopenic. In healthy seniors, 2.8% of women and 3.6% of men were sarcopenic (MMI). The prevalence was 23.6% in women and 12.5% in men with SMI. MMI and SMI identified different sarcopenic populations, leaner subjects for MMI while fatter subjects for SMI.Conclusion: Cutoff values for the French population were defined. Prevalence of sarcopenia was different from that in the US population.

Key word

Sarcopenia muscle mass aging frail elderly bioelectrical impedance analysis 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Rosenberg IH Summary comments: epidemiological and methodological problems in determining nutritional status of older persons. Am J Clin Nutr 1989;50: 1231–3Google Scholar
  2. 2.
    Janssen I, Heymsfield SB & Ross R Low relative skeletal muscle mass (sarcopenia) in older persons is associated with functional impairment and physical disability. J Am Geriatr Soc 2002;50: 889–96.PubMedCrossRefGoogle Scholar
  3. 3.
    Janssen I, Baumgartner RN, Ross R, Rosenberg IH, Roubenoff R. Skeletal muscle cutpoints associated with elevated physical disability risk in older men and women. Am J Epidemiol. 2004;159: 413–21PubMedCrossRefGoogle Scholar
  4. 4.
    Janssen I, Ross R. Linking age-related changes in skeletal muscle mass and composition with metabolism and disease. J Nutr Health Aging. 2005;9: 408–19PubMedGoogle Scholar
  5. 5.
    Janssen I. Influence of sarcopenia on the development of physical disability: the Cardiovascular Health Study. J Am Geriatr Soc. 2006;4: 56–62CrossRefGoogle Scholar
  6. 6.
    Baumgartner RN, Koehler KM, Gallagher D, Romero L, Heymsfield SB, Ross RR, Garry PJ & Lindeman RD Epidemiology of sarcopenia among the elderly in New Mexico. Am J Epidemiol 1998;147: 755–63.PubMedGoogle Scholar
  7. 7.
    Visser M, Goodpaster BH, Kritchevsky SB, Newman AB, Nevitt M, Rubin SM, Simonsick EM, Harris TB. Muscle mass, muscle strength, and muscle fat infiltration as predictors of incident mobility limitations in well-functioning older persons. J Gerontol A Bid Sci Med Sci. 2005;60: 324–33Google Scholar
  8. 8.
    Wang ZM, Visser M, Ma R, Baumgartner RN, Kotier D, Gallagher D & Heymsfield SB Skeletal muscle mass: evaluation of neutron activation and dual-energy X-ray absorptiometry methods. J Appl Physiol 1996;80: 824–31.PubMedGoogle Scholar
  9. 9.
    Janssen I, Heymsfield SB, Baumgartner RN & Ross R. Estimation of skeletal muscle mass by bioelectrical impedance analysis. J Appl Physiol 2000; 89: 465–71.PubMedGoogle Scholar
  10. 10.
    Rolland Y, Lauwers-Cances V, Cournot M, Nourhashemi F, Reynish W, Riviere D, Vellas B, Grandjean H. Sarcopenia, calf circumference, and physical function of elderly women: a cross-sectional study. J Am Geriatr Soc. 2003;51: 1120–4.PubMedCrossRefGoogle Scholar
  11. 11.
    Szulc P, Duboeuf F, Marchand F, Delmas PD. Hormonal and lifestyle determinants of appendicular skeletal muscle mass in men: the MINOS study. Am J Clin Nutr. 2004;80: 496–503.PubMedGoogle Scholar
  12. 12.
    Lau EM, Lynn HS, Woo JW, Kwok TC, Melton LJ 3rd. Prevalence of and risk factors for sarcopenia in elderly Chinese men and women. J Gerontol. 2005;60: 213–6CrossRefGoogle Scholar
  13. 13.
    Baumgartner RN, Wayne SJ, Waters DL, Janssen I, Gallagher D, Morley JE. Sarcopenic obesity predicts instrumental activities of daily living disability in the elderly. Obes Res. 2004;12: 1995–2004.PubMedCrossRefGoogle Scholar
  14. 14.
    Baumgartner RN. Body composition in healthy aging. Ann N Y Acad Sci. 2000;904: 437–48.PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag France and Serdi Éditions 2008

Authors and Affiliations

  • J. Tichet
    • 1
  • S. Vol
    • 1
  • D. Goxe
    • 2
  • A. Salle
    • 3
    • 4
  • G. Berrut
    • 5
  • P. Ritz
    • 3
    • 4
  1. 1.IRSALa RicheFrance
  2. 2.IRSAAngers
  3. 3.Nutrition departmentFrance
  4. 4.Inserm UMR 694France
  5. 5.Gerontology department3,4,5 CHUAngersFrance
  6. 6.Pôle de maladies métaboliques et médecine interne-CHUANGERS CEDEX 01

Personalised recommendations